Research is an important part of what we do in CETAC to ensure the advancement of treatments for patients like yourself. There are many positive reasons to participate in research but there are NO OBLIGATIONS to do so.
When participating in a study, you will be closely cared for by a team of experts familiar with the most cutting edge treatments. Many research participants have reported back to us that they derive satisfaction in knowing they are helping to advance medical care by contributing to new knowledge. Many find that they gain more knowledge about their own condition and potentially benefit from treatment not yet available to other patients. In this section, we highlight some of our current research studies. Feel free to speak to your CETAC physician or the research coordinator about these studies.
TINZAPARIN s/c injections versus DOAC: influence on Post-Thrombotic Syndrome (PTS) after first Common Femoral or Iliac DVT
Read More
Patients with a clinically confirmed diagnosis of leg Post-Thrombotic Syndrome (Villalta score ≥ 5) will be randomized for 6 months duration treatment with either Micronized Purified Flavonoid Fraction (Venixxa) or Placebo.
Read More
Statins for Venous Event Reduction in Patients with Venous Thromboembolism Pilot
Read More
Step-down to prophylactic (preventative) dose of enoxaparin (a blood thinner currently being used and approved by Health Canada) after 3-6 months of anticoagulation for the treatment of cancer-associated thrombosis
Read More
